Literature DB >> 21056060

Depressive-like profile induced by MCH microinjections into the dorsal raphe nucleus evaluated in the forced swim test.

Patricia Lagos1, Jessika Urbanavicius, María Cecilia Scorza, Rodrigo Miraballes, Pablo Torterolo.   

Abstract

Antagonism of the melanin-concentrating hormone (MCH) receptor 1 (MCH-R1) has been recently shown to have antidepressant-like profile in rats. However, the mechanisms by which the MCHergic system participates in the modulation of emotional states are still to be determined. In the present study we confirmed the presence of MCHergic fibers within the dorsal raphe nucleus (DRN), a serotonergic nucleus involved in the physiopathology of major depression. We also assessed the effects of the administration of MCH and anti-MCH antibody (immunoneutralization) into the DRN using the forced swim test in rats, an animal model to screen antidepressant drugs. We found that a low dose of MCH (50 ng) evoked a depressive-like behavior indicated by a significant increase in the immobility time as well as a decrease in climbing behavior. Furthermore, the depressive-like response was prevented by pretreatment with fluoxetine. Consistent with these results, the immunoneutralization of MCH produced an antidepressant-like effect. By means of the open field test we discarded that these effects were related to unspecific changes in motor activity. Our results suggest that the MCHergic neurons are involved in the regulation of emotional behaviors through the modulation of the serotonergic neuronal activity within the DRN. In addition, the present results are in agreement with previous reports showing that antagonism of the MCHergic system may be a novel therapeutic strategy for the treatment of depressive disorders.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21056060     DOI: 10.1016/j.bbr.2010.10.035

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  16 in total

1.  The melanin-concentrating hormone (MCH) system in an animal model of depression-like behavior.

Authors:  M J García-Fuster; G S Parks; S M Clinton; S J Watson; H Akil; O Civelli
Journal:  Eur Neuropsychopharmacol       Date:  2011-12-29       Impact factor: 4.600

2.  Melanin-concentrating hormone neurons contribute to dysregulation of rapid eye movement sleep in narcolepsy.

Authors:  Fumito Naganuma; Sathyajit S Bandaru; Gianna Absi; Carrie E Mahoney; Thomas E Scammell; Ramalingam Vetrivelan
Journal:  Neurobiol Dis       Date:  2018-08-24       Impact factor: 5.996

3.  Acute escitalopram treatment inhibits REM sleep rebound and activation of MCH-expressing neurons in the lateral hypothalamus after long term selective REM sleep deprivation.

Authors:  Zita Kátai; Csaba Adori; Tamás Kitka; Szilvia Vas; Lajos Kalmár; Diána Kostyalik; László Tóthfalusi; Miklós Palkovits; György Bagdy
Journal:  Psychopharmacology (Berl)       Date:  2013-03-21       Impact factor: 4.530

Review 4.  Sleep-Wake Neurobiology.

Authors:  Giancarlo Vanini; Pablo Torterolo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Melanin-concentrating hormone: a new sleep factor?

Authors:  Pablo Torterolo; Patricia Lagos; Jaime M Monti
Journal:  Front Neurol       Date:  2011-03-18       Impact factor: 4.003

6.  Peripheral injections of melanin-concentrating hormone receptor 1 antagonist S38151 decrease food intake and body weight in rodent obesity models.

Authors:  Odile Della-Zuana; Valérie Audinot; Viviane Levenez; Alain Ktorza; Françoise Presse; Jean-Louis Nahon; Jean A Boutin
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-21       Impact factor: 5.555

Review 7.  Melanin-Concentrating Hormone (MCH): Role in REM Sleep and Depression.

Authors:  Pablo Torterolo; Cecilia Scorza; Patricia Lagos; Jessika Urbanavicius; Luciana Benedetto; Claudia Pascovich; Ximena López-Hill; Michael H Chase; Jaime M Monti
Journal:  Front Neurosci       Date:  2015-12-17       Impact factor: 4.677

8.  The role of melanin concentrating hormone (MCH) in the central chemoreflex: a knockdown study by siRNA in the lateral hypothalamus in rats.

Authors:  Ningjing Li; Eugene Nattie; Aihua Li
Journal:  PLoS One       Date:  2014-08-01       Impact factor: 3.240

9.  Subchronical treatment with Fluoxetine modifies the activity of the MCHergic and hypocretinergic systems. Evidences from peptide CSF concentration and gene expression.

Authors:  Bruno F Calegare; Alicia Costa; Leandro Fernandes; Ana L Dias; Pablo Torterolo; Vânia D' Almeida
Journal:  Sleep Sci       Date:  2016-06-07

10.  Novel analgesic effects of melanin-concentrating hormone on persistent neuropathic and inflammatory pain in mice.

Authors:  Jae-Hwan Jang; Ji-Yeun Park; Ju-Young Oh; Sun-Jeong Bae; Hyunchul Jang; Songhee Jeon; Jongpil Kim; Hi-Joon Park
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.